1Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the national comorbidity survey replication(NCS-R) [J].JAMA, 2003, 289 : 3095-3105. 被引量：1
6Nemeroff CB, Owens MJ. Pharmacologic dlferences amongthe SSRls.. focus on monoamine transporters and the HPA axis[J]. CNS Spectr, 2004, 9:23-31. 被引量：1
7Finfgeld DL.Serotonin syndrome and the use of SSRIs [J].j Psychosoc Nuts Ment Health Serv, 2004, 42(2) : 16-20. 被引量：1
8Masand PS, Gupta S. Long-ten'n side elects of newer-generation antidepres-sants: SSRIs, venlafaxine, nefazodone, bupropion, and mirtazapine[J]. Ann Clin Psychiatry, 2002, 14 (3) : 175-182. 被引量：1
5De Berardis D, Valchera A, Fornaro M, et al. Agomela- tine reversal of escitalopram-induced apathy: a case report [J]. Psychiatry Clin Neurosci, 2013,67 ( 3 ) : 190. 被引量：1
6Carney RM, Shelton RC. Agomelatine for the treatment of major depressive disorder[J]. Expert Opin Pharmacoth- er,2011,12(15) :2 411. 被引量：1
7Srinivasan V, Zakaria R, Othman Z, et al. Agomelatine in depressive disorders: its novel mechanisms of action [J]. J Neuropsychiatty Clin Neurosci, 2012,24 (3) : 290. 被引量：1
8Courtet P, Olid E. Circadian dimension and severity of de- pression[J].Eur Neuropsychopharmacol, 2012, 22 (Suppl 3) : S476. 被引量：1
9Lam RW. Onset, time course and trajectories of improve- ment with antidepressants[J]. Eur Neuropsychopharma- col, 2012,22 (Suppl 3) : S492. 被引量：1
10Tiuvina NA, Smirnova VN. A comparative evaluation of the efficacy of valdoxan (agomelatine) in recurrent de-pression and bipolar affective disorder[J]. Zh Nevrol Psikhiatr lm S S Korsakova , 2 012,112 ( 11 ) : 5 3. 被引量：1
